Skip to main content
Top
Published in: Current Nutrition Reports 4/2019

01-12-2019 | Nutrition | Gastroenterology, Critical Care, and Lifestyle Medicine (SA McClave, Section Editor)

Practices Involved in the Enteral Delivery of Drugs

Authors: Kathryn S. Bandy, Stephanie Albrecht, Bhavyata Parag, Stephen A. McClave

Published in: Current Nutrition Reports | Issue 4/2019

Login to get access

Abstract

Purpose of Review

While the delivery of medications through enteral tubes is common in critically ill patients, there are complications and a lack of unified practices between institutions. The purpose of this review is to evaluate current practices and literature evidence regarding this administration route. The effect of this administration on the medication’s efficacy, safety, tolerability, and pharmacokinetics was examined, as well as other considerations to ensure that this route of delivery is both safe and effective for patients.

Recent Findings

Studies have found crushed oral tablets are the most frequent cause of obstructed feeding tubes. Complications such as this are primarily due to inadequate personnel training and failure to properly access medications before enteral administration.

Summary

There are many factors that should be considered in order to effectively administer drugs via enteral tubes. Formal training and use of a multi-disciplinary approach that includes pharmacists and dieticians has been shown to reduce tube obstructions and administration errors.
Literature
1.
go back to reference Nathwani D, Lawson W, Dryden M, Stephens J, Corman S, Solem C, et al. Implementing criteria-based early switch/early discharge programmes: a European perspective. Clin Microbiol Infect. 2015;21(Suppl 2):S47–55.CrossRef Nathwani D, Lawson W, Dryden M, Stephens J, Corman S, Solem C, et al. Implementing criteria-based early switch/early discharge programmes: a European perspective. Clin Microbiol Infect. 2015;21(Suppl 2):S47–55.CrossRef
2.
go back to reference Cyriac JM, James E. Switch over from intravenous to oral therapy: a concise overview. J Pharmacol Pharmacother. 2014;5(2):83–7.CrossRef Cyriac JM, James E. Switch over from intravenous to oral therapy: a concise overview. J Pharmacol Pharmacother. 2014;5(2):83–7.CrossRef
3.
go back to reference Paladino JA, Sperry HE, Backes JM, Gelber JA, Serrianne DJ, Cumbo TJ, et al. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics. Am J Med. 1991;91(5):462–70.CrossRef Paladino JA, Sperry HE, Backes JM, Gelber JA, Serrianne DJ, Cumbo TJ, et al. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics. Am J Med. 1991;91(5):462–70.CrossRef
4.
go back to reference Belknap DC, Seifert CF, Petermann M. Administration of medications through enteral feeding catheters. Am J Crit Care. 1997;6(5):382–92.CrossRef Belknap DC, Seifert CF, Petermann M. Administration of medications through enteral feeding catheters. Am J Crit Care. 1997;6(5):382–92.CrossRef
5.
go back to reference Gora ML, Tschampel MM, Visconti JA. Considerations of drug therapy in patients receiving enteral nutrition. Nutr Clin Pract. 1989;4(3):105–10.CrossRef Gora ML, Tschampel MM, Visconti JA. Considerations of drug therapy in patients receiving enteral nutrition. Nutr Clin Pract. 1989;4(3):105–10.CrossRef
6.•
go back to reference Institute for Safe Medication Practices (ISMP). Oral dosage forms that should not be crushed. Assessed at ismp.org. Updated 2019. This is an online resource provided by ISMP that lists oral medications that should not be crushed. The list also provides reasoning for the recommendations. Institute for Safe Medication Practices (ISMP). Oral dosage forms that should not be crushed. Assessed at ismp.​org. Updated 2019. This is an online resource provided by ISMP that lists oral medications that should not be crushed. The list also provides reasoning for the recommendations.
8.
go back to reference Beckwith MC, Feddema SS, Barton RG, Graves C. A guide to drug therapy in patients with enteral feeding tubes: dosage form selection and administration methods. Hosp Pharm. 2004;39(3):225–37.CrossRef Beckwith MC, Feddema SS, Barton RG, Graves C. A guide to drug therapy in patients with enteral feeding tubes: dosage form selection and administration methods. Hosp Pharm. 2004;39(3):225–37.CrossRef
9.
go back to reference Leff RD, Roberts RJ. Enteral drug administration practices: report of a preliminary survey. Pediatrics. 1988;81(4):549–51.PubMed Leff RD, Roberts RJ. Enteral drug administration practices: report of a preliminary survey. Pediatrics. 1988;81(4):549–51.PubMed
10.
go back to reference Van den bemt PM, Cusell MB, Overbeeke PW, et al. Quality improvement of oral medication administration in patients with enteral feeding tubes. Qual Saf Health Care 2006;15(1):44–47. Van den bemt PM, Cusell MB, Overbeeke PW, et al. Quality improvement of oral medication administration in patients with enteral feeding tubes. Qual Saf Health Care 2006;15(1):44–47.
11.
go back to reference Sacks GS. Drug-nutrient considerations in patients receiving parenteral and enteral nutrition. Pract Gastroenterol. 2004;28(7):39–48. Sacks GS. Drug-nutrient considerations in patients receiving parenteral and enteral nutrition. Pract Gastroenterol. 2004;28(7):39–48.
12.
go back to reference Bankhead R, Boullata J, Brantley S, Corkins M, Guenter P, Krenitsky J, et al. Enteral nutrition practice recommendations. JPEN J Parenter Enteral Nutr. 2009;33(2):122–67.CrossRef Bankhead R, Boullata J, Brantley S, Corkins M, Guenter P, Krenitsky J, et al. Enteral nutrition practice recommendations. JPEN J Parenter Enteral Nutr. 2009;33(2):122–67.CrossRef
13.
go back to reference Mcintyre CM, Monk HM. Medication absorption considerations in patients with postpyloric enteral feeding tubes. Am J Health Syst Pharm. 2014;71(7):549–56.CrossRef Mcintyre CM, Monk HM. Medication absorption considerations in patients with postpyloric enteral feeding tubes. Am J Health Syst Pharm. 2014;71(7):549–56.CrossRef
14.
go back to reference Klang M, Mclymont V, Ng N. Osmolality, pH, and compatibility of selected oral liquid medications with an enteral nutrition product. JPEN J Parenter Enteral Nutr. 2013;37(5):689–94.CrossRef Klang M, Mclymont V, Ng N. Osmolality, pH, and compatibility of selected oral liquid medications with an enteral nutrition product. JPEN J Parenter Enteral Nutr. 2013;37(5):689–94.CrossRef
15.
go back to reference Hill DB, Henderson LM, Mcclain CJ. Osmotic diarrhea induced by sugar-free theophylline solution in critically ill patients. JPEN J Parenter Enteral Nutr. 1991;15(3):332–6.CrossRef Hill DB, Henderson LM, Mcclain CJ. Osmotic diarrhea induced by sugar-free theophylline solution in critically ill patients. JPEN J Parenter Enteral Nutr. 1991;15(3):332–6.CrossRef
16.•
go back to reference De brito-ashurst I, Preiser JC. Diarrhea in critically ill patients: the role of enteral feeding. JPEN J Parenter Enteral Nutr. 2016;40(7):913–23. This review article discusses a common issue in patients receiving enteral nutrition, diarrhea. The article highlights the potential etiologies, specifically considerations with medications that are administered via EN tubes. CrossRef De brito-ashurst I, Preiser JC. Diarrhea in critically ill patients: the role of enteral feeding. JPEN J Parenter Enteral Nutr. 2016;40(7):913–23. This review article discusses a common issue in patients receiving enteral nutrition, diarrhea. The article highlights the potential etiologies, specifically considerations with medications that are administered via EN tubes. CrossRef
17.
go back to reference Chang SJ, Huang HH. Diarrhea in enterally fed patients: blame the diet? Curr Opin Clin Nutr Metab Care. 2013;16(5):588–94.CrossRef Chang SJ, Huang HH. Diarrhea in enterally fed patients: blame the diet? Curr Opin Clin Nutr Metab Care. 2013;16(5):588–94.CrossRef
18.
go back to reference Lutomski DM, Gora ML, Wright SM, Martin JE. Sorbitol content of selected oral liquids. Ann Pharmacother. 1993;27(3):269–74.CrossRef Lutomski DM, Gora ML, Wright SM, Martin JE. Sorbitol content of selected oral liquids. Ann Pharmacother. 1993;27(3):269–74.CrossRef
19.
go back to reference Estoup M. Approaches and limitations of medication delivery in patients with enteral feeding tubes. Crit Care Nurse. 1994;14(1):68–72 77-9.CrossRef Estoup M. Approaches and limitations of medication delivery in patients with enteral feeding tubes. Crit Care Nurse. 1994;14(1):68–72 77-9.CrossRef
22.
go back to reference American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder, Third Edition. 2010. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder, Third Edition. 2010.
23.•
go back to reference American Pain Society. Pain Management and Dosing Guide. 2016. Assessed from americanpainsociety.org. This includes the most recent guidelines for pain management from the American Pain Society. These guidelines discuss morphine equivalents and provide recommendations for transitioning between opioids. American Pain Society. Pain Management and Dosing Guide. 2016. Assessed from americanpainsoci​ety.​org. This includes the most recent guidelines for pain management from the American Pain Society. These guidelines discuss morphine equivalents and provide recommendations for transitioning between opioids.
Metadata
Title
Practices Involved in the Enteral Delivery of Drugs
Authors
Kathryn S. Bandy
Stephanie Albrecht
Bhavyata Parag
Stephen A. McClave
Publication date
01-12-2019
Publisher
Springer US
Keyword
Nutrition
Published in
Current Nutrition Reports / Issue 4/2019
Electronic ISSN: 2161-3311
DOI
https://doi.org/10.1007/s13668-019-00290-4

Other articles of this Issue 4/2019

Current Nutrition Reports 4/2019 Go to the issue

Gastroenterology, Critical Care, and Lifestyle Medicine (SA McClave, Section Editor)

Premixed vs Compounded Parenteral Nutrition: Effects of Total Parenteral Nutrition Shortage on Clinical Practice

Gastroenterology, Critical Care, and Lifestyle Medicine (SA McClave, Section Editor)

Protein Supplementation in Sport: Source, Timing, and Intended Benefits

Gastroenterology, Critical Care, and Lifestyle Medicine (SA McClave, Section Editor)

Multiple Health Benefits and Minimal Risks Associated with Vegetarian Diets

Gastroenterology, Critical Care, and Lifestyle Medicine (SA McClave, Section Editor)

Mitochondrial Dysfunction in Critical Illness: Implications for Nutritional Therapy

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.